Herpes simplex virus: treatment with antimicrobial peptides
- PMID: 17713025
- DOI: 10.1007/978-0-387-72005-0_39
Herpes simplex virus: treatment with antimicrobial peptides
Abstract
The herpes virus infection represents a significant challenge for public health. The innate immunity plays an important role in herpes simplex virus (HSV) elimination. The innate antiviral immunity has not been comprehensively studied. The recent investigations demonstrate that Toll-like receptors are actively involved in the virus recognition. The complement and natural antibodies, as well as cytokines and antimicrobial peptides, are the first molecules to bind to virions. In this chapter, some mechanisms of the innate antiviral immunity are discussed and treatment regimens are proposed. The complex of native cytokines and antimicrobial peptides (CCAP or Superlymph) proved to inhibit the virus reproduction in vitro. Protegrines, as a CCAP component, were active against the virus. Considering all the data, we conclude that the complex of native cytokines and antimicrobial peptides produces both immunomodulating and antiviral effects.
Similar articles
-
Toll-like receptors as novel therapeutic targets for herpes simplex virus infection.Rev Med Virol. 2019 Jul;29(4):e2048. doi: 10.1002/rmv.2048. Epub 2019 Jul 2. Rev Med Virol. 2019. PMID: 31265195 Review.
-
In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus.Mem Inst Oswaldo Cruz. 2007 Jun;102(4):469-72. doi: 10.1590/s0074-02762007005000028. Mem Inst Oswaldo Cruz. 2007. PMID: 17612767
-
Recognition of herpes simplex viruses: toll-like receptors and beyond.J Mol Biol. 2014 Mar 20;426(6):1133-47. doi: 10.1016/j.jmb.2013.11.012. Epub 2013 Nov 19. J Mol Biol. 2014. PMID: 24262390 Free PMC article. Review.
-
A new promising candidate to overcome drug resistant herpes simplex virus infections.Antiviral Res. 2018 Jan;149:202-210. doi: 10.1016/j.antiviral.2017.11.012. Epub 2017 Nov 15. Antiviral Res. 2018. PMID: 29155164
-
Peptide inhibitors against herpes simplex virus infections.J Pept Sci. 2013 Mar;19(3):148-58. doi: 10.1002/psc.2489. Epub 2013 Feb 7. J Pept Sci. 2013. PMID: 23389903 Review.
Cited by
-
Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases.New Microbes New Infect. 2019 Dec 10;34:100627. doi: 10.1016/j.nmni.2019.100627. eCollection 2020 Mar. New Microbes New Infect. 2019. PMID: 31993204 Free PMC article. Review.
-
In vitro studies of the antiherpetic effect of photodynamic therapy.Lasers Med Sci. 2016 Jul;31(5):849-55. doi: 10.1007/s10103-016-1912-0. Epub 2016 Mar 22. Lasers Med Sci. 2016. PMID: 27003896
-
Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.J Biol Chem. 2012 Aug 31;287(36):30181-90. doi: 10.1074/jbc.M112.370312. Epub 2012 Jul 12. J Biol Chem. 2012. PMID: 22791717 Free PMC article.
-
The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Clin Dev Immunol. 2013;2013:369172. doi: 10.1155/2013/369172. Epub 2013 Mar 31. Clin Dev Immunol. 2013. PMID: 23606868 Free PMC article. Review.
-
Intracellular mechanism of antimicrobial peptide HJH-3 against Salmonella pullorum.RSC Adv. 2022 May 13;12(23):14485-14491. doi: 10.1039/d2ra01363k. eCollection 2022 May 12. RSC Adv. 2022. PMID: 35702236 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical